Ignite Creation Date:
2025-12-18 @ 9:11 AM
Ignite Modification Date:
2025-12-18 @ 9:11 AM
Study NCT ID:
NCT00038649
Status:
None
Last Update Posted:
2018-10-09 00:00:00
First Post:
2002-06-03 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-06
Start Date Type:
None
Primary Completion Date:
2013-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11
Completion Date Type:
ACTUAL
First Submit Date:
2002-06-03 00:00:00
First Submit QC Date:
None
Study First Post Date:
2002-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-19 00:00:00
Results First Submit QC Date:
None
Results First Post Date:
2018-10-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-11 00:00:00
Last Update Post Date:
2018-10-09 00:00:00
Last Update Post Date Type:
ACTUAL